Sale!

Immunophenotyping by Flow Cytometry CD22 Test Cost

Original price was: 530 د.إ.Current price is: 480 د.إ.

-9%

The “Immunophenotyping by Flow Cytometry CD22 Test” is a sophisticated diagnostic procedure offered by DNA Labs UAE, priced at 480 AED. This test is specifically designed to analyze and quantify the presence of the CD22 antigen on the surface of white blood cells, primarily B lymphocytes. CD22 is a critical marker involved in the regulation of B-cell function and the immune response. Its expression levels can provide valuable insights into various hematological disorders, including certain types of leukemia and lymphoma.

Flow cytometry, the technology utilized in this test, enables the rapid and accurate measurement of CD22 expression by passing thousands of cells through a laser beam and detecting the cells that are tagged with fluorescently labeled antibodies specific to the CD22 protein. This method not only allows for the precise identification of cell populations with CD22 expression but also assesses the intensity of expression, providing crucial information for diagnosis, prognosis, and monitoring of treatment efficacy in patients with related disorders.

Performed at the state-of-the-art facilities of DNA Labs UAE, this test is a vital tool in the clinical assessment and management of patients with suspected or confirmed hematological malignancies, offering a fast, reliable, and detailed analysis of CD22 expression levels.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD22 Test

At DNA Labs UAE, we offer the CD22 test, a type of immunophenotyping test performed using flow cytometry. This test is useful for identifying and characterizing B cells based on the expression of CD22, a cell surface protein primarily found on B cells.

Test Cost

The cost of the CD22 test is AED 480.0.

Test Components

  • 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube
  • 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube

Ship the samples immediately at 18°C–22°C. Do not refrigerate or freeze. Specify the time, date, and clinical details on the test request form.

Report Delivery

The sample is delivered daily by 9 am, and the report is available on the same day.

Method

The CD22 test is performed using flow cytometry, a specialized instrument that can analyze and sort cells based on their size, shape, and fluorescence.

Test Type

The CD22 test is used for cancer diagnosis, specifically in identifying and characterizing B cells.

Doctor

The CD22 test is usually requested by oncologists or hematologists.

Test Department

The CD22 test is performed in the FLOW CYTOMETRY department.

Pre Test Information

Please provide a brief clinical history when requesting the CD22 test.

Test Details

The CD22 test is a valuable tool in immunophenotyping. It involves collecting a sample of blood or bone marrow from the patient. The sample is then treated with fluorescently-labeled antibodies that specifically bind to CD22, allowing for the detection and quantification of CD22-positive B cells.

The sample is run through a flow cytometer, which uses laser beams to excite the fluorescently-labeled antibodies bound to CD22. The emitted light at specific wavelengths is detected by the instrument, generating a fluorescence profile for each cell. This allows for the identification and enumeration of CD22-positive B cells.

The results of the CD22 test provide valuable information about the B cell population in the patient’s sample. Abnormalities in CD22 expression patterns can indicate certain diseases, such as B-cell lymphomas or leukemias. The CD22 test can also be used to monitor the effectiveness of treatments targeting B cells, such as immunotherapies.

In summary, the CD22 test offered by DNA Labs UAE is a valuable tool in immunophenotyping, allowing for the identification and characterization of CD22-positive B cells using flow cytometry.

Test Name IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD22 Test
Components
Price 480.0 AED
Sample Condition 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form.
Report Delivery Sample Daily by 9 am; Report Same day
Method Flow Cytometry
Test type Cancer
Doctor Oncologist, Hematologist
Test Department: FLOW CYTOMETRY
Pre Test Information Give brief clinical history.
Test Details

The CD22 test is a type of immunophenotyping test performed using flow cytometry. CD22 is a cell surface protein that is primarily expressed on B cells, making it a useful marker for identifying and characterizing these cells.

During the test, a sample of blood or bone marrow is collected from the patient. The sample is then treated with fluorescently-labeled antibodies that specifically bind to CD22. These antibodies allow for the detection and quantification of CD22-positive B cells.

The sample is then run through a flow cytometer, a specialized instrument that can analyze and sort cells based on their size, shape, and fluorescence. As the sample passes through the flow cytometer, laser beams excite the fluorescently-labeled antibodies bound to CD22, causing them to emit light at specific wavelengths. The instrument detects this emitted light and generates a fluorescence profile for each cell, allowing for the identification and enumeration of CD22-positive B cells.

The results of the CD22 test can provide valuable information about the B cell population in the patient’s sample. Abnormalities in CD22 expression patterns can be indicative of certain diseases, such as B-cell lymphomas or leukemias. Additionally, the CD22 test can be used to monitor the effectiveness of treatments targeting B cells, such as immunotherapies.

Overall, the CD22 test is a valuable tool in immunophenotyping, allowing for the identification and characterization of CD22-positive B cells using flow cytometry.